
Anti-tumor effect of the alphavirus-based virus-like particle vector expressing prostate-specific antigen in a HLA-DR transgenic mouse model of prostate cancer
Keywords: TC-83 virus; VLPV; PSA; Prostate cancer; Vaccine; DR2b mice; PSA; Prostate-Specific Antigen; VLPV-PSA; virus-like particle vector encoding PSA; TRAMP-PSA; Transgenic Adenocarcinoma of Mouse Prostate cells engineered to express PSA; VEEV; Venezuelan eq